Internet of Things for Diabetes Market
Internet of Things for Diabetes Market Size and Growth
The Internet of Things (IoT) for Diabetes market is rapidly expanding, driven by increasing demand for remote monitoring and management solutions. The market size was valued at approximately $XX billion in 2023 and is projected to grow significantly, reflecting a rising prevalence of diabetes and the adoption of digital health technologies.
Companies Covered
(Covid 19 Impact Covered)
◍ Ascensia Diabetes Care Holdings AG
◍ LifeScan
◍ Medtronic
◍ Novo Nordisk
◍ Alien Technology
◍ BioTelemetry
◍ WellDoc
◍ Otsuka(Proteus Digital Health)
◍ Diabetizer Ltd
◍ GlySens
◍ CRF Health(Entra Health Systems LLC)
◍ Dexcom, Inc
The Internet of Things (IoT) for diabetes market features companies like Ascensia, LifeScan, and Medtronic, which utilize connected devices for glucose monitoring and management. These firms enhance patient care, data tracking, and adherence. For example:
- Dexcom generated approximately $1.5 billion in 2022. - Medtronic's diabetes business reported $2.5 billion in revenue.
- Novo Nordisk recorded $2.3 billion from diabetesrelated products.
Request Sample Report
Market Segmentation
By Application
By Product
Services ◍ Hospitals & Clinics ◍ Diagnostic Centers ◍ Rehabilitation Centers
Others
Request Sample Report
Medical Devices
Systems and Software
$ 36.65 Billion
Request Sample Report
